LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Jun 18, 2024
Product Development
Tumor cell surface targets off the beaten path
Beyond the headlines at ASCO and AACR were a set of less traveled cancer targets, including neuronal proteins hijacked by solid tumors
Read More
BioCentury
|
Jun 8, 2023
Discovery & Translation
Modalities, not targets, drive translational innovation at ASCO23
BioCentury’s analysis of first-in-human studies at ASCO 2023
Read More
BioCentury
|
May 18, 2023
Regulation
May 18 Quick Takes: Vaccines panel backs Pfizer RSV vaccine
Plus: Pressure mounts on CMS over Alzheimer’s therapies, financing updates for Coherent, Myeloid, Cabaletta, RedCloud, CytoCares, and more
Read More
BioCentury
|
Feb 29, 2016
Clinical News
SOR-C13: Phase I data
Read More
BioCentury
|
Jan 18, 2016
Clinical News
SOR-C13: Completed Phase I enrollment
Read More
BioCentury
|
Aug 20, 2012
Clinical News
SOR-C13: Phase I started
Read More
BioCentury
|
Jul 23, 2012
Company News
Soricimed, Mount Allison University deal
Read More
Items per page:
10
1 - 7 of 7